×

CoLucid Pharmaceuticals to Present Corporate Overview at the Stifel 2015 Healthcare Conference

CAMBRIDGE, Mass., Nov. 12, 2015 (GLOBE NEWSWIRE) -- CoLucid Pharmaceuticals, Inc. (NASDAQ:CLCD) today announced that Thomas Mathers, Chief Executive Officer, will present a corporate overview at the Stifel 2015 Healthcare Conference.

Stifel 2015 Healthcare Conference
Date: Wednesday, November 18, 2015
Time: 8:00am Eastern Time
Location: Hubbard Room, The New York Palace Hotel
Webcast: http://www.veracast.com/webcasts/stifel/healthcare2015/05201687339.cfm

About CoLucid Pharmaceuticals, Inc.

CoLucid was founded in 2005 and is developing oral lasmiditan for the acute treatment of migraine headaches in adults and intravenous lasmiditan for the acute treatment of unspecified headache pain in adults in emergency room and other urgent care settings.

CONTACT: Thomas Mathers Chief Executive Officer CoLucid Pharmaceuticals, Inc. (781) 365-2596 Hans Vitzthum Managing Director LifeSci Advisors, LLC. (212) 915-2568Source:CoLucid Pharmaceuticals, Inc